Microdosing protocols typically involve splitting the weekly dose into two or more smaller injections spread across the week
From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
Embracing a holistic approach is key
Its essential for anyone with underlying health conditions to consult with a healthcare provider to determine if B12 injections are safe and appropriate for their specific needs
Bryson Richards please contact us at 702.870.7070 Taking new patients from Las Vegas, Bullhead City, Laughlin, Pahrump, Mesquite NV and surrounding areas.
Fontella FU, Pulrolnik V, Gassen E, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2000) Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats
